Dr Reddy's launches generic attention deficit disorder drug in US market

New Delhi, Sep 3 () Dr Reddy's Laboratories on Thursday said it has launched Methylphenidate Hydrochloride extended-release tablets, used to treat attention deficit disorder (ADD), in the US market.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news

Related Links:

Source: International Journal of Oral and Maxillofacial Surgery - Category: ENT & OMF Source Type: research
Though the comparison is a bit apples and oranges between now and 1918, the staggering death toll is tragic in any era.Medscape Medical News
Source: Medscape Emergency Medicine Headlines - Category: Emergency Medicine Tags: Infectious Diseases News Source Type: news
A new report claims better federal government coordination is needed, along with an improved public health infrastructure, more tests, and better data on critical supplies.Medscape Medical News
Source: Medscape Pharmacist Headlines - Category: Drugs & Pharmacology Tags: Infectious Diseases News Source Type: news
Pediatric Dermatology Part I
Source: Dermatologic Clinics - Category: Dermatology Source Type: research
Esther E. Freeman and Devon E. McMahon
Source: Dermatologic Clinics - Category: Dermatology Source Type: research
BRUCE H. THIERS, MD
Source: Dermatologic Clinics - Category: Dermatology Source Type: research
ELSEVIER
Source: Dermatologic Clinics - Category: Dermatology Source Type: research
DERMATOLOGIC CLINICS
Source: Dermatologic Clinics - Category: Dermatology Authors: Source Type: research
Source: The American Journal of Cardiology - Category: Cardiology Source Type: research
Source: The American Journal of Cardiology - Category: Cardiology Source Type: research
More News: Biotechnology | Concerta | Methylphenidate | Pharmaceuticals | Ritalin